ZA200804921B - Novel N-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4 - Google Patents

Novel N-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4

Info

Publication number
ZA200804921B
ZA200804921B ZA200804921A ZA200804921A ZA200804921B ZA 200804921 B ZA200804921 B ZA 200804921B ZA 200804921 A ZA200804921 A ZA 200804921A ZA 200804921 A ZA200804921 A ZA 200804921A ZA 200804921 B ZA200804921 B ZA 200804921B
Authority
ZA
South Africa
Prior art keywords
phenylsulfonamides
pyrazinyl
modulators
fluoro
novel
Prior art date
Application number
ZA200804921A
Other languages
English (en)
Inventor
Cheshire David
Kindon Nicholas
Mete Antonio
Roberts Bryan
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200804921B publication Critical patent/ZA200804921B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C07D241/22—Benzenesulfonamido pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA200804921A 2005-12-12 2008-06-05 Novel N-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4 ZA200804921B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0502733 2005-12-12

Publications (1)

Publication Number Publication Date
ZA200804921B true ZA200804921B (en) 2009-09-30

Family

ID=38163190

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200804921A ZA200804921B (en) 2005-12-12 2008-06-05 Novel N-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4

Country Status (21)

Country Link
US (2) US20080293742A1 (xx)
EP (1) EP1968951B1 (xx)
JP (1) JP2009519332A (xx)
KR (1) KR20080091139A (xx)
CN (1) CN101370793B (xx)
AR (1) AR058319A1 (xx)
AT (1) ATE513819T1 (xx)
AU (1) AU2006325573A1 (xx)
BR (1) BRPI0619602A2 (xx)
CA (1) CA2631342A1 (xx)
CL (1) CL2006003449A1 (xx)
EC (1) ECSP088603A (xx)
ES (1) ES2366807T3 (xx)
HK (1) HK1121760A1 (xx)
IL (1) IL191761A0 (xx)
NO (1) NO20083070L (xx)
RU (1) RU2008122401A (xx)
TW (1) TW200730512A (xx)
UY (1) UY29999A1 (xx)
WO (1) WO2007069978A1 (xx)
ZA (1) ZA200804921B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI328007B (en) * 2002-01-16 2010-08-01 Astrazeneca Ab Novel compounds
ES2474615T3 (es) * 2009-04-22 2014-07-09 Axikin Pharmaceuticals, Inc. Antagonistas de CCR3 arilsulfonamidas 2,5-disustituidas
ES2939606T3 (es) * 2013-09-02 2023-04-25 Univ Melbourne Un método de tratamiento
CN104447756A (zh) * 2014-11-10 2015-03-25 常州大学 一种五氟磺草胺中间体的制备方法
CN104402890A (zh) * 2014-11-10 2015-03-11 常州大学 一种制备五氟磺草胺的方法
AU2018360766A1 (en) 2017-11-06 2020-05-21 Rapt Therapeutics, Inc. Anticancer agents
CN110028501B (zh) 2018-01-12 2022-02-22 迈德欣国际有限公司 化合物及其制备方法和用途
CN108929279A (zh) * 2018-07-27 2018-12-04 同济大学 一种含氟氨基吡嗪类化合物及其制备方法与应用
CN113893220A (zh) * 2020-07-07 2022-01-07 迈德欣国际有限公司 鼻粘膜给药剂型和其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928151A (en) * 1959-07-14 1963-06-06 Farmaceutici Italia Pyrazine derivatives
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CZ291386B6 (cs) 1996-02-13 2003-02-12 Zeneca Limited Chinazolinové deriváty jako inhibitory VEGF, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
ES2169355T3 (es) 1996-03-05 2002-07-01 Astrazeneca Ab Derivados de 4-anilinoquinazolina.
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
US6638937B2 (en) * 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
EP1289952A1 (en) 2000-05-31 2003-03-12 AstraZeneca AB Indole derivatives with vascular damaging activity
EP1301497A1 (en) 2000-07-07 2003-04-16 Angiogene Pharmaceuticals Limited Colchinol derivatives as vascular damaging agents
CA2410562A1 (en) 2000-07-07 2002-01-31 Angiogene Pharmaceuticals Limited Colchinol derivatives as angiogenesis inhibitors
SE0102439D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
AU2002358390A1 (en) 2001-12-18 2003-06-30 Astrazeneca Ab Novel compounds
TWI328007B (en) * 2002-01-16 2010-08-01 Astrazeneca Ab Novel compounds
SE0301650D0 (sv) * 2003-06-04 2003-06-04 Astrazeneca Ab Novel compounds
SE0301654D0 (sv) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
SE0301653D0 (sv) * 2003-06-05 2003-06-05 Astrazeneca Ab Novel compounds
SE0302304D0 (sv) * 2003-08-27 2003-08-27 Astrazeneca Ab Novel compounds

Also Published As

Publication number Publication date
US20100144759A1 (en) 2010-06-10
CN101370793B (zh) 2012-01-04
HK1121760A1 (en) 2009-04-30
CN101370793A (zh) 2009-02-18
JP2009519332A (ja) 2009-05-14
CA2631342A1 (en) 2007-06-21
IL191761A0 (en) 2008-12-29
ES2366807T3 (es) 2011-10-25
WO2007069978A1 (en) 2007-06-21
AU2006325573A1 (en) 2007-06-21
ECSP088603A (es) 2008-08-29
TW200730512A (en) 2007-08-16
US20080293742A1 (en) 2008-11-27
BRPI0619602A2 (pt) 2011-10-11
AR058319A1 (es) 2008-01-30
NO20083070L (no) 2008-08-28
RU2008122401A (ru) 2010-01-20
UY29999A1 (es) 2007-07-31
KR20080091139A (ko) 2008-10-09
EP1968951B1 (en) 2011-06-22
ATE513819T1 (de) 2011-07-15
CL2006003449A1 (es) 2008-02-08
EP1968951A1 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
TWI366458B (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
ZA200804921B (en) Novel N-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor CCR4
IL179018A0 (en) 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
IL179910A0 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
CY2017008I2 (el) Νεες ενωσεις ως διαμορφωτες υποδοχεα οπιοειδων
IL192976A (en) Piperidinyl derivatives as modulators of receptor activity as mucin
AP2008004487A0 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
EP1656138A4 (en) SUBSTITUTED CYCLOALKYAMINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
IL179843A0 (en) N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP1807076A4 (en) N- (PYRIDIN-3-YL) -2-PHENYLBUTANAMIDES AS ANDROGEN RECEPTOR MODULATORS
ZA200806028B (en) Modulators of muscarinic receptors
IL176720A0 (en) Chemokine ccr5 receptor modulators
IL175958A0 (en) Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
IL178650A0 (en) Piperidine derivatives as modulators of chemokine receptor ccr5
EP1716134A4 (en) AMINO HETEROCYCLIC COMPOUNDS MODULATING CHEMOKINE RECEPTOR ACTIVITY
EP1890696A4 (en) Suitable as new ORL-1 receptor modulators are 3-pyrolytic indolyl derivatives
ZA200606199B (en) Novel piperidines as chemokine modulators (CCR)
IL179729A0 (en) Novel piperidine derivates as modulators of chemokine receptor ccr5
IL188856A0 (en) Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases
SI2049519T1 (sl) Cikliäśni derivati kot modulatorji kemokinske receptorske aktivnosti
EP1912945A4 (en) N- (PYRIDIN-4-YL) -2-PHENYLBUTANAMIDES AS MODULATORS OF THE ANDROGEN RECEPTOR
ZA200806875B (en) Piperidinyl derivatives as modulators of chemokine receptor activity
EP1631286A4 (en) N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
EP1682105A4 (en) N-UREIDOALKYL-AMINO COMPOUNDS AS MODULATORS OF CHEMOKIN RECEPTOR ACTIVITY
ZA200804438B (en) 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors